C/EBPβ Cooperates With MYB to Maintain the Oncogenic Program of AML Cells
oncotarget.net,
PRESS RELEASE: on March 11, 2023, a new editorial perspective was published in Oncotarget, entitled, “C/EBPβ cooperates with…
PRESS RELEASE: on March 11, 2023, a new editorial perspective was published in Oncotarget, entitled, “C/EBPβ cooperates with…
“This makes C/EBPβ an interesting pro-oncogenic player in AML, worthy of further studies.” BUFFALO, NY- November 13, 2023 …